BioCentury
ARTICLE | Company News

Martek, OmegaTech deal

April 1, 2002 8:00 AM UTC

MATK will acquire OmegaTech, a producer of docosahexaenoic acid (DHA), for 1.8 million shares valued at $56.97 million based on MATK's Friday close at $31.65. OmegaTech investors also may receive an a...